Prognostic significance of previous tonsillectomy after radical cystectomy for bladder cancer

References

• Gakis G. The role of inflammation in bladder cancer. Adv Exp Med Biol. 2014; 816:183–196.
   PubMed Web of Science ®Google Scholar
• Mischinger J, Comperat E, Schwentner C, et al. Inflammation and cancer: what can we therapeutically expect from checkpoint inhibitors? Curr Urol Rep. 2015;16:59.
   PubMed Web of Science ®Google Scholar
• Sui X, Lei L, Chen L, et al. Inflammatory microenvironment in the initiation and progression of bladder cancer. Oncotarget. 2017;8:93279–93294.
   PubMedGoogle Scholar
• Schubert T, Renninger M, Schmid MA, et al. Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer. Urol Oncol. 2020; 38:e74–e15.
   PubMed Web of Science ®Google Scholar
• Nasrin M, Miah MR, Datta PG, et al. Effect of tonsillectomy on humoral immunity. Bangladesh Med Res Counc Bull. 2012;38:59–61.
   PubMedGoogle Scholar
• Baugh RF, Archer SM, Mitchell RB, et al.; American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg. 2011;144:S1–S30.
   PubMed Web of Science ®Google Scholar
• Byars SG, Stearns SC, Boomsma JJ. Association of Long-Term Risk of Respiratory, Allergic, and Infectious Diseases With Removal of Adenoids and Tonsils in Childhood. JAMA Otolaryngol Head Neck Surg. 2018;144:594–603.
   PubMed Web of Science ®Google Scholar
• Whittemore AS, Paffenbarger RS, Jr., Anderson K, et al. Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst. 1985;74:43–51.
   PubMedGoogle Scholar
• Sun LM, Chen HJ, Li TC, et al. A nationwide population-based cohort study on tonsillectomy and subsequent cancer incidence. Laryngoscope. 2015;125:134–139.
   PubMed Web of Science ®Google Scholar
• Gakis G, Efstathiou J, Lerner SP, et al.; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013;63:45–57.
   PubMed Web of Science ®Google Scholar
• Gakis G, Todenhofer T, Renninger M, et al. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score. BJU Int. 2011;108:1800–1805.
   PubMed Web of Science ®Google Scholar
• Potretzke A, Hillman L, Wong K, et al. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder. Urol Oncol. 2014;32:631–636.
   PubMed Web of Science ®Google Scholar
• Schubert T, Todenhofer T, Mischinger J, et al. The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer. World J Urol. 2016;34:829–834.
   PubMed Web of Science ®Google Scholar
• Gakis G, Fritsche HM, Hassan F, et al. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Eur J Cancer. 2014;50:2583–2591.
   PubMed Web of Science ®Google Scholar
• Todenhofer T, Renninger M, Schwentner C, et al. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. BJU Int. 2012;110:E533–E540.
   PubMed Web of Science ®Google Scholar
• Chen Z, Ding W, Xu K, et al. The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer. PLOS One. 2012;7:e47199.
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–1474.
   PubMed Web of Science ®Google Scholar
• Cheng L, Montironi R, Davidson DD, et al. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol. 2009; 22 (Suppl 2):S70–S95.
   PubMed Web of Science ®Google Scholar
• Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N + M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. Lancet Oncol. 2015;16:76–86.
   PubMed Web of Science ®Google Scholar
• Witjes JA, Babjuk M, Bellmunt J, et al. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multistakeholder effort: under the auspices of the EAU-ESMO Guidelines Committees. Eur Urol. 2019;30:1697–1727.
   Google Scholar
• Gakis G, Black PC, Bochner BH, et al. Systematic review on the fate of the remnant urothelium after radical cystectomy. Eur Urol. 2017;71:545–557.
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675.
   PubMed Web of Science ®Google Scholar
• Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol. 2005;23:6533–6539.
   PubMed Web of Science ®Google Scholar
• Stroman L, Nair R, Russell B, et al. The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy. BJU Int. 2019;124:418–423.
   PubMed Web of Science ®Google Scholar
• Bae WK, Lee HJ, Park SH, et al. Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: a retrospective analysis: KCSG GU 17-03. Cancer Med. 2019;8:5431–5437.
   PubMed Web of Science ®Google Scholar
• Cope JU, Askling J, Gridley G, et al. Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden. Pediatrics. 2003;111:1343–1350.
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Song H, Cao Y, et al. Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy. Scand J Gastroenterol. 2016;51:583–589.
   PubMed Web of Science ®Google Scholar
• Cornu JN, Neuzillet Y, Herve JM, et al. Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer. World J Urol. 2012;30:821–826.
   PubMed Web of Science ®Google Scholar
• Weise JB, Meyer JE, Helmer H, et al. A newly discovered function of palatine tonsils in immune defence: the expression of defensins. Otolaryngol Pol. 2002;56:409–413.
   PubMedGoogle Scholar
• Vestergaard H, Wohlfahrt J, Westergaard T, et al. Incidence of tonsillectomy in Denmark, 1980 to 2001. Pediatr Infect Dis J. 2007;26:1117–1121.
   PubMed Web of Science ®Google Scholar
• Altwairqi RG, Aljuaid SM, Alqahtani AS. Effect of tonsillectomy on humeral and cellular immunity: a systematic review of published studies from 2009 to 2019. Eur Arch Otorhinolaryngol. 2020;277:1–7.
   PubMed Web of Science ®Google Scholar
• Ji J, Sundquist J, Sundquist K. Tonsillectomy associated with an increased risk of autoimmune diseases: a national cohort study. J Autoimmun. 2016;72:1–7.
   PubMed Web of Science ®Google Scholar
• Lubin JH, Burns PE, Blot WJ, et al. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst. 1982;68:211–217.
   PubMedGoogle Scholar
• Brasky TM, Bonner MR, Dorn J, et al. Tonsillectomy and breast cancer risk in the Western New York Diet Study. Cancer Causes Control. 2009;20:369–374.
   PubMed Web of Science ®Google Scholar
• Johnston JJ, Douglas R. Adenotonsillar microbiome: an update. Postgrad Med J. 2018;94:398–403.
   PubMed Web of Science ®Google Scholar
• Bellmunt J, de Wit R, Vaughn DJ, et al.; KEYNOTE-045 Investigators. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017;376:1015–1026.
   PubMed Web of Science ®Google Scholar
• Rajagopala SV, Vashee S, Oldfield LM, et al. The human microbiome and cancer. Cancer Prev Res (Phila). 2017;10:226–234.
   PubMed Web of Science ®Google Scholar
• Markowski MC, Boorjian SA, Burton JP, et al. The microbiome and genitourinary cancer: a collaborative review. Eur Urol. 2019;75:637–646.
   PubMed Web of Science ®Google Scholar
• Dhar NB, Jones JS, Reuther AM, et al. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder. BJU Int. 2008;101:969–972.
   PubMed Web of Science ®Google Scholar
• Mitra AP, Alemozaffar M, Harris BN, et al. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology. 2014;84:1420–1426.
   PubMed Web of Science ®Google Scholar
• Prior AJ, Drake-Lee AB. Auditing the reliability of recall of patients for minor surgical procedures. Clin Otolaryngol Allied Sci. 1991;16:373–375.
   PubMed Web of Science ®Google Scholar
• Porter MP, Kerrigan MC, Donato BM, et al. Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol. 2011;29:252–258.
   PubMed Web of Science ®Google Scholar